Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidylprolyl isomerase A pseudogene 5 (PPIAP5) is a non-protein-coding pseudogene in the human genome, classified formally on genetic databases such as NCBI and GeneCards[1][3][5]. PPIAP5 bears sequence similarity to the active gene peptidylprolyl isomerase A (PPIA), which encodes the enzyme cyclophilin A involved in protein folding and is implicated in a range of biological and disease processes[4]. However, PPIAP5 itself does not produce a functional protein and has no known physiological role or therapeutic relevance. It is included in lists of pseudogenes under the caution flag indicating strong suspicion of non-coding status, and its annotation is stable across major databases[2]. There are no known aliases or alternative names beyond PPIAP5, and the gene has not been associated with any disease roles, drug interactions, mechanisms of action, biomarkers, or safety/tolerability issues. It should not be considered a therapeutic target or molecular receptor, and its inclusion in structured target lists would be incorrect[1][2][3][5].
None applicable; there are no pharmaceutical mechanisms targeting PPIAP5[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 5 (PPIAP5).